Suppr超能文献

载 PEDF 的间充质干细胞衍生的小细胞外囊泡通过增加 PEDF 的稳定性和穿透性增强对氧诱导性视网膜病变的治疗效果。

Enhanced therapeutic effect of PEDF-loaded mesenchymal stem cell-derived small extracellular vesicles against oxygen-induced retinopathy through increased stability and penetrability of PEDF.

机构信息

Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute, School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, 300384, China.

出版信息

J Nanobiotechnology. 2023 Sep 8;21(1):327. doi: 10.1186/s12951-023-02066-z.

Abstract

BACKGROUND

Several common retinal diseases that cause blindness are characterised by pathological neovascularisation accompanied by inflammation and neurodegeneration, including retinopathy of prematurity (ROP), diabetic retinopathy (DR), age-related macular degeneration (AMD), and retinal vein occlusion (RVO). The current treatment strategies for these diseases have limited benefits. Thus, safer and more effective alternative approaches are required. In this study, we loaded small extracellular vesicles (sEVs) derived from mesenchymal stem cell (MSC) with pigment epithelium-derived factor (PEDF), and tested the therapeutic effect of PEDF-loaded sEVs (PEDF-sEVs) using an oxygen induced retinopathy (OIR) mouse model, aiming to establish a new therapy strategy for the treatment of retinal pathological angiogenesis.

RESULTS

We formulated PEDF-loaded sEVs (PEDF-sEVs) containing high concentrations of PEDF and evaluated their effects through in vivo and in vitro experiments. In OIR mice, PEDF-sEVs showed significantly better effects on retinal avascular areas, inflammation, and neuronal degeneration compared with the anti-vascular endothelial growth factor (VEGF) drug, which may indicate a possible advantage of PEDF-sEVs over anti-VEGF drugs in the treatment of pathological neovascularisation. In vitro, PEDF-sEVs greatly inhibited endothelial cell (EC) proliferation, migration, and tube formation by suppressing the VEGF-induced phosphorylation of extracellular signal-regulated kinase (ERK) and AKT (also known as Protein Kinase B). All experiments and analyses were performed in triplicate. PEDF-sEVs were more effective than PEDF or sEVs alone, both in vitro and in vivo. Furthermore, to determine the distribution of PEDF-sEVs, we used DiD-labelled sEVs and FITC-labelled PEDF to track the sEVs and PEDF, respectively. We found that PEDF-sEVs effectively reduced the degradation of PEDF.

CONCLUSIONS

Loading PEDF on sEVs effectively enhanced the anti-angiogenic, anti-inflammatory, and neuroprotective effects of PEDF by increasing the stability and penetrability. These results suggest a potential role for PEDF-sEVs in retinal pathological neovascularisation.

摘要

背景

几种常见的致盲性视网膜疾病的特征是病理性新生血管形成,伴有炎症和神经退行性变,包括早产儿视网膜病变(ROP)、糖尿病性视网膜病变(DR)、年龄相关性黄斑变性(AMD)和视网膜静脉阻塞(RVO)。目前这些疾病的治疗策略获益有限。因此,需要更安全、更有效的替代方法。在这项研究中,我们将间充质干细胞(MSC)来源的小细胞外囊泡(sEVs)装载色素上皮衍生因子(PEDF),并用氧诱导的视网膜病变(OIR)小鼠模型测试 PEDF 负载 sEVs(PEDF-sEVs)的治疗效果,旨在为治疗视网膜病理性血管生成建立一种新的治疗策略。

结果

我们构建了含有高浓度 PEDF 的 PEDF 负载 sEVs(PEDF-sEVs),并通过体内和体外实验评估了它们的效果。在 OIR 小鼠中,与抗血管内皮生长因子(VEGF)药物相比,PEDF-sEVs 对视网膜无血管区、炎症和神经元变性的作用明显更好,这可能表明 PEDF-sEVs 在治疗病理性新生血管形成方面可能优于抗 VEGF 药物。体外实验中,PEDF-sEVs 通过抑制血管内皮生长因子(VEGF)诱导的细胞外信号调节激酶(ERK)和 AKT(也称为蛋白激酶 B)磷酸化,极大地抑制了内皮细胞(EC)的增殖、迁移和管形成。所有实验和分析均重复了三次。PEDF-sEVs 无论是在体内还是体外,都比 PEDF 或 sEVs 单独使用更有效。此外,为了确定 PEDF-sEVs 的分布,我们使用 DiD 标记的 sEVs 和 FITC 标记的 PEDF 分别追踪 sEVs 和 PEDF。我们发现 PEDF-sEVs 有效地减少了 PEDF 的降解。

结论

将 PEDF 加载到 sEVs 上可通过增加稳定性和穿透性有效增强 PEDF 的抗血管生成、抗炎和神经保护作用。这些结果表明 PEDF-sEVs 在视网膜病理性新生血管形成中具有潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2e0/10492320/1370047f106a/12951_2023_2066_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验